-
psnet.ahrq.gov/node/36699/psn-pdf
March 28, 2011 - Hospital staff should use more than one method to detect
adverse events and potential adverse events: incident
reporting, pharmacist surveillance and local real-time
record review may all have a place.
March 28, 2011
Olsen S, Neale G, Schwab K, et al. Hospital staff should use more than one method to detect advers…
-
digital.ahrq.gov/location/usa-mo-st-louis
January 01, 2023 - USA, MO, St. Louis
EnhanCed HandOffs (ECHO)
Description
This research will develop and evaluate a machine learning-augmented and telemedicine-augmented sociotechnical intervention for postoperative handoffs to reduce the risks of patient complications and improve patient-cen…
-
psnet.ahrq.gov/web-mm/novel-drug-misuse
September 30, 2010 - that the commentary does not include information about or discuss investigational or off-label use of pharmaceutical … products or medical devices. … addition, the commentary does not include information regarding investigational or off-label use of pharmaceutical … products or medical devices. … July 14, 2010
Adverse events associated with sedatives, analgesics, and other drugs that
-
effectivehealthcare.ahrq.gov/sites/default/files/introduction-to-user-guide-overview.pptx
January 01, 2013 - In addition, new drugs and other interventions often lack comparative efficacy data to quantify a therapy
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZTMgupsEkCUuuPVpeGUm45
September 01, 2013 - Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive
Services Task Force Recommendation Statement
Virginia A. Moyer, MD, MPH, on behalf of the U.S. Preventive Services Task Force*
Description: Update of the 2004 U.S. Preventive Services Task
Force (USPSTF) recommendation on screening for and treatment …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - We
considered all drugs for induction
and maintenance, regardless of
how they are indicated. … Response
Public: Abbott Results, KQ3 Consider distinguishing between injection site reactions for drugs … given subcutaneously
(adalimumab, certolizumab, ustekinimab) versus infusion reactions for drugs that … Naltrexone is the first new class of drugs to be tested and shown
to be efficacious in Crohn’s disease … Efforts should be
made to move the FDA to approve generic drugs like naltrexone for this new indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pilot-projects-supplementing-white-paper.pdf
December 01, 2024 - the pilot projects required an additional 283, 425, and 595
total hours for Minnesota (osteoporosis drugs
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary27/screening-depression-suicide-risk-children-adolescents
October 11, 2022 - Fourth, the review was limited to first-line drugs approved for pediatric use by the FDA. … https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications … Suicidality in pediatric patients treated with antidepressant drugs. … but 9 were conducted exclusively in adolescents
Pharmacotherapy studies were limited to first-line drugs … but 5 were conducted exclusively in adolescents
Pharmacotherapy studies were limited to first-line drugs
-
www.ahrq.gov/sites/default/files/2024-03/bruzzese2-report.pdf
January 01, 2024 - antibiotics for infections, chemotherapy for
cancer, insulin for diabetes, and pain medication, among other drugs
-
integrationacademy.ahrq.gov/products/playbooks/moud-playbook/monitor-patient-outcomes/tracking-patient-outcomes
August 01, 2025 - other clinical and quality of life outcome measures. 23 Continued Substance Use: Continuing to use drugs
-
digital.ahrq.gov/funding-mechanism/ambulatory-safety-and-quality-program-improving-quality-through-clinician-use
January 01, 2023 - Ambulatory Safety and Quality Program: Improving Quality through Clinician Use of Health IT (R18)
Factors associated with ordering laboratory monitoring of high-risk medications.
Citation
Fischer SH, Tjia J, Reed G, et al. Factors associated with ordering laboratory monitoring…
-
psnet.ahrq.gov/issue/patient-safety-perceptions-primary-care-providers-after-implementation-electronic-medical
December 21, 2014 - Study
Patient safety perceptions of primary care providers after implementation of an electronic medical record system.
Citation Text:
McGuire MJ, Noronha G, Samal L, et al. Patient safety perceptions of primary care providers after implementation of an electronic medical record system. …
-
psnet.ahrq.gov/issue/structured-approach-ehr-surveillance-diagnostic-error-acute-care-exploratory-analysis-two
October 16, 2024 - Study
A structured approach to EHR surveillance of diagnostic error in acute care: an exploratory analysis of two institutionally-defined case cohorts.
Citation Text:
Malik MA, Motta-Calderon D, Piniella N, et al. A structured approach to EHR surveillance of diagnostic error in acute car…
-
psnet.ahrq.gov/issue/automated-identification-postoperative-complications-within-electronic-medical-record-using
March 09, 2011 - Study
Classic
Automated identification of postoperative complications within an electronic medical record using natural language processing.
Citation Text:
Murff HJ, FitzHenry F, Matheny ME, et al. Automated identification of postoperative complications within a…
-
psnet.ahrq.gov/issue/integrating-and-evaluating-data-quality-and-utility-smart-pump-information-detecting
September 09, 2020 - Study
Integrating and evaluating the data quality and utility of smart pump information in detecting medication administration errors: evaluation study.
Citation Text:
Ni Y, Lingren T, Huth H, et al. Integrating and evaluating the data quality and utility of smart pump information in det…
-
digital.ahrq.gov/ahrq-funded-projects/computer-assisted-medication-and-patient-information-interface-campii/annual-summary/2012
January 01, 2012 - Computer Assisted Medication and Patient Information Interface - 2012
Project Name
Computer Assisted Medication and Patient Information Interface (CAMPII)
Principal Investigator
Ziemer, David C.
Organization
Emory University
Funding Mechanism
RFA: HS08-269: Explorat…
-
psnet.ahrq.gov/issue/association-note-quality-and-quality-care-cross-sectional-study
June 05, 2018 - Study
Association of note quality and quality of care: a cross-sectional study.
Citation Text:
Edwards ST, Neri PM, Volk LA, et al. Association of note quality and quality of care: a cross-sectional study. BMJ Qual Saf. 2014;23(5):406-13. doi:10.1136/bmjqs-2013-002194.
Copy Citation
…
-
psnet.ahrq.gov/issue/patient-initiated-voluntary-online-survey-adverse-medical-events-perspective-696-injured
May 20, 2020 - Study
Classic
A patient-initiated voluntary online survey of adverse medical events: the perspective of 696 injured patients and families.
Citation Text:
Southwick FS, Cranley NM, Hallisy JA. A patient-initiated voluntary online survey of adverse medical events:…
-
psnet.ahrq.gov/issue/utilising-improvement-science-methods-optimise-medication-reconciliation
July 24, 2017 - Study
Utilising improvement science methods to optimise medication reconciliation.
Citation Text:
White CM, Schoettker PJ, Conway PH, et al. Utilising improvement science methods to optimise medication reconciliation. BMJ Qual Saf. 2011;20(4):372-80. doi:10.1136/bmjqs.2010.047845.
Co…
-
digital.ahrq.gov/sites/default/files/docs/citation/enhancedmedhistories_102611comp.pdf
October 01, 2011 - Reminder rates for elderly patients taking at least two drugs from the list of
“Drugs to Avoid in … But as may be seen from Table 20 and 21, drugs from the HEDIS list of “Drugs to
Avoid in the Elderly … Reminder rates for elderly patients taking at least two drugs from the list of “Drugs to Avoid in the … most frequent Drugs to Avoid in the Elderly. … Drugs To Be Avoided in the Elderly
Category 5.